The dose may be increased in 2.5 mg increments every four weeks as needed, based on your progress and tolerance
Wegovy is also a once-weekly injection, where users start at 0.25 mg for the first month before increasing to 0.5 mg
Rehfeld JF, Knop FK, Asmar A, Madsbad S, Holst JJ, Asmar M
With regular application, it minimizes the appearance of fine lines and helps maintain elasticity
In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time